. Author manuscript; available in PMC: 2024 Mar 8.

Published in final edited form as: J Allergy Clin Immunol Pract. 2023 Oct 31;12(2):372–382.e2. doi: 10.1016/j.jaip.2023.10.044

TABLE IV.

General health—related QoL (SF-8) and work productivity impairments in participants with WRA and non-WRA compared with the reference population^*^†

Outcomes	Missing values	WRA (n = 89)	Non-WRA (n = 119)	Reference group (n = 815)	P value (non-WRA group vs reference group)
SF8-PCS score	1/5/42	46.4 (38.6–51.5)	51.8 (46.4–56.2)	54.4 (50.0–56.9)	.001
SF8-MCS score	1/5/42	45.7 (36.6–52.4)	50.7 (43.9–56.3)	52.4 (48.2–57.5)	.016
Any work time missed (absenteeism)	11/8/90	14 (17.9)	5 (4.5)	19 (2.6)	.469
Any impairment at work (presenteeism)	19/11/132	33 (47.1)	25 (23.1)	58 (8.5)	<.01
Any overall work impairment	21/11/139	31 (45.6)	27 (25.0)	58 (8.6)	<.01
Any activity impairment	7/6/56	45 (54.9)	32 (28.3)	77 (10.1)	<.01

Data are presented as number (% of available data) of subjects or medians (interquartile ranges).

Comparisons between the 3 groups were all significant (P < .001).

^†

Comparison between the WRA group vs the non-WRA group, as well as the WRA group vs the reference group were all significant (P < .01).